血清多配体蛋白聚糖1、血管紧张素转换酶2与川崎病患儿冠状动脉损害和临床疗效的关系OACSTPCD
Relationship between serum syndecan-1,angiotensin-converting enzyme 2 and coronary artery lesions in chil-dren with Kawasaki disease and clinical efficacy
目的 研究血清多配体蛋白聚糖1(syndecan-1,SDC-1)、血管紧张素转换酶2(angiotensin-converting enzyme 2,ACE2)与川崎病(Kawasaki disease,KD)患儿冠状动脉损害(coronary artery lesions,CAL)和临床疗效的关系.方法 选取2020年6月至2022年3月收治的113例KD急性期患儿作为研究对象并设为KD组,治疗前行超声心动图检查,根据检查结果分为CAL组(n…查看全部>>
Objective To investigate the relationship between serum syndecan-1(SDC-1),angiotensin-converting enzyme 2(ACE2),coronary artery lesions(CAL),and clinical efficacy in children with Kawasaki disease(KD).Methods A total of 113 children with acute KD from June 2020 to March 2022 were enrolled as the KD group.Ultrasonic echocardiography was performed before treatment,and patients were divided into the CAL group(n=39)and non-CAL group(n=74)based on the results.Add…查看全部>>
王从贵;彭海琳;熊伟
成都市青白江区妇幼保健院儿科(四川成都 610306)成都市青白江区妇幼保健院儿科(四川成都 610306)成都市青白江区妇幼保健院儿科(四川成都 610306)
临床医学
川崎病多配体蛋白聚糖1血管紧张素转换酶2冠状动脉损害疗效预测价值
Kawasaki diseasesyndecan-1angiotensin converting enzyme 2coronary artery lesionefficacypredictive value
《广东医学》 2024 (6)
666-671,6
四川省医学科研课题计划(S2020246)
评论